HIV and Tuberculosis: a Deadly Human Syndemic
Open accessThe DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.
Abstract
SUMMARY: A syndemic is defined as the convergence of two or more diseases that act synergistically to magnify the burden of disease. The intersection and syndemic interaction between the human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics have had deadly consequences around the world. Without adequate control of the TB-HIV syndemic, the long-term TB elimination target set for 2050 will not be reached. There is an urgent need for additional resources and novel approaches for the diagnosis, treatment, and prevention of both HIV and TB. Moreover, multidisciplinary approaches that consider HIV and TB together, rather than as separate problems and diseases, will be necessary to prevent further worsening of the HIV-TB syndemic. This review examines current knowledge of the state and impact of the HIV-TB syndemic and reviews the epidemiological, clinical, cellular, and molecular interactions between HIV and TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Originally focused on vulnerable communities in high-income countries (HICs) [ 1 ], more recently, a syndemics approach has been applied in low- and middle-income countries (LMICs) [ 13–15 ].”
From Syndemic contexts: findings from a review of research on non-communicable diseases and interviews with experts (2021) · cites this paper as [14]
In the citing paper
“Studies show that HIV co-infection, which increases the risk of latent TB reactivation 20-fold, is the most powerful known risk factor for the progression of Mycobacterium tuberculosis infection to an active disease [16,17].”
From Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia (2014) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Odhiambo, J. A., Borgdorff, M. W., Kiambih, F. M., Kibuga, D. K., Kwamanga, D. O., Ng'ang'a, L., Agwanda, R., Kalisvaart, N. A., Misljenovic, O., Nagelkerke, N. J., et al. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.7.1078 · Cited by 76 · cited 1×
“One early study in Kenya found that the ARTI increased from 1986 to 1996 in a setting of high HIV prevalence, which suggested an increased rate of transmission of TB (202).”
BackgroundHIV-Associated Tuberculosis: Diagnostic and Treatment Challenges
El‐Sadr, W., & Tsiouris, S. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1085703 · Cited by 75 · cited 2×
“Although pulmonary TB is the most common presentation regardless of the stage of HIV infection, persons with advanced immune suppression are more likely to have extrapulmonary TB than are HIV-infected persons with relatively intact immunity or persons without HIV (15, 33, 83, 136).”
BackgroundMorris, L., Martin, D. J., Bredell, H., Nyoka, S., Sacks, L. V., Pendle, S., Page‐Shipp, L., Karp, C. L., Sterling, T. R., Quinn, T. C., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/375346 · Cited by 75 · cited 26×
“The use of NVP with rifampin was associated with higher rates of virologic failure starting at 6 months after the initiation of treatment in a South African prospective cohort study (29).”
BackgroundInfluentialPastores, S. M., Naidich, D. P., Aranda, C. P., McGuinnes, G. M. G. C. T., & Rom, W. N. (1993) · CHEST Journal · doi:10.1378/chest.103.5.1433 · Cited by 74 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodSutherland, R. K., Yang, H., Scriba, T. J., Ondondo, B., Robinson, N., Conlon, C. P., Suttill, A., McShane, H., Fidler, S. J., McMichael, A. J., et al. (2006) · AIDS · doi:10.1097/01.aids.0000218545.31716.a4 · Cited by 72 · cited 7×
“More recently, CD4 cells from HIV-infected patients who had undetectable HIV in plasma after treatment with ART for a minimum of 1 year were found to exhibit defective IFNsecretion in response to stimulation with M. tuberculosis purified protein derivative (PPD) (241).”
BackgroundInfluentialIannello, A., Tremblay, C., Routy, J.-P., Boulassel, M.-R., Toma, E., & Ahmad, A. (2008) · Viral Immunology · doi:10.1089/vim.2008.0025 · Cited by 71 · cited 1×
“T cell counts (130, 131), indicating that CD4 T cells are an”
BackgroundTiming of Antiretroviral Therapy Initiation in Tuberculosis Patients With AIDS: A Decision Analysis
Schiffer, J. T., & Sterling, T. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802e2975 · Cited by 69 · cited 1×
“A comparison of three hypothetical cohorts of TB-HIV-coinfected patients in whom ART was initiated during the first 8 weeks or during weeks 8 through 24 or not initiated during TB treatment predicted that early ART initiation had the highest survival benefit (33 estimated deaths per 1,000 patients) compared to the gro…”
ResultFactors Affecting the Yield of Acid-fast Sputum Smears in Patients With HIV and Tuberculosis
Smith, R. L., Yew, K., Berkowitz, K. A., & Aranda, C. P. (1994) · Chest · doi:10.1378/chest.106.3.684 · Cited by 67 · cited 2×
“However, when adjusted for the presence of cavities, the yield of a sputum smear from HIV-infected persons can be similar to that of a sputum smear from HIV-uninfected persons (33, 175, 233).”
BackgroundResultManagement of patients with the immune reconstitution inflammatory syndrome
Marais, S., Wilkinson, R. J., Pepper, D. J., & Meintjes, G. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0022-z · Cited by 66 · cited 1×
“More recently, a double-blind placebo-controlled randomized trial evaluating the use of prednisone for TB-IRIS in 109 study participants in South Africa (median CD4 count, 53 cells/ l) found a reduction in days of hospitalization and numbers of procedures for study participants who received prednisone (173, 185).”
BackgroundClinical and radiographic features of HIV-related tuberculosis1
Burman, W. J. (2003) · Seminars in Respiratory Infections · doi:10.1053/s0882-0546(03)00072-0 · Cited by 62 · cited 10×
“At all stages of HIV infection, pulmonary TB is the most common form of TB (33).”
BackgroundInfluentialTransmission of Mycobacterium tuberculosis to Contacts of HIV-infected Tuberculosis Patients
Carvalho, A. C. C., DeRiemer, K., NUNES, Z. B., Martins, M., Comelli, M., Marinoni, A., & Kritski, A. L. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.12.2103078 · Cited by 59
An analysis of the epitope knowledge related to Mycobacteria
Blythe, M., Zhang, Q. H., Vaughan, K. C., de Castro, R., Salimi, N., Bui, H., Lewinsohn, D. M., Ernst, J., Peters, B., & Sette, A. (2007) · Immunome Research · doi:10.1186/1745-7580-3-10 · Cited by 59 · cited 1×
“(23) and multiple methods of identifying and characterizing”
Self-citation(2006) · PsycEXTRA Dataset · doi:10.1037/e521222006-001 · Cited by 58
Sanguanwongse, N., Cain, K. P., Suriya, P., Nateniyom, S., Yamada, N., Wattanaamornkiat, W., Sumnapan, S., Sattayawuthipong, W., Kaewsa-ard, S., Ingkaseth, S., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318177594e · Cited by 58 · cited 1×
“A prospective cohort study of HIV-infected TB patients in Thailand found that those who received ART during TB treatment had one-sixth the risk of death compared to those who did not receive ART (222).”
BackgroundGirardi, E., Antonucci, G., Vanacore, P., Palmieri, F., Matteelli, A., Iemoli, E., Carradori, S., Salassa, B., Pasticci, M. B., Raviglione, M. C., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00109303 · Cited by 58 · cited 1×
“Additionally, treatment with ART and the restoration of cell-mediated immunity are associated with less extrapulmonary involvement in TB infection (112).”
BackgroundYang, Y., Tomura, M., 岩崎, 正., Mukai, T., Gao, P., Ono, S., Zou, J.-P., Shearer, G. M., Fujiwara, H., & Hamaoka, T. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011059906777 · Cited by 55 · cited 2×
“The chemokine ligands that use CCR5 (MIP-1 /CCL3, MIP-1 /CCL4, and RANTES/CCL5) effectively compete with HIV for CCR5 and inhibit the infection of CCR5-expressing cells (148).”
BackgroundSabin, F. R., & Doan, C. A. (1927) · The Journal of Experimental Medicine · doi:10.1084/jem.46.4.627 · Cited by 55 · cited 1×
“tuberculosis resides in macrophages has been known at least since the studies of Sabin and colleagues in the 1920s (65, 220), although the spectrum of cells in which the bacteria reside in vivo has been recently found to include myeloid dendritic cells (129, 244, 269).”
ResultKenyon, T. A., Creek, T., Laserson, K. F., Makhoa, M., Chimidza, N., Mwasekaga, M., Tappero, J. W., Lockman, S., Moeti, T. L., & BINKIN, N. J. (2002) · PubMed · Cited by 55
Ahmed, A. B., Abubakar, I., Delpech, V., Lipman, M. C. I., Boccia, D., Forde, J., Antoine, D., & Watson, J. M. (2007) · Thorax · doi:10.1136/thx.2006.072611 · Cited by 54 · cited 1×
“In England and Wales, nearly one-third of the increase in numbers of cases of TB from 1999 to 2003 occurred in HIVinfected patients (8).”
BackgroundThe Changing Natural History of Tuberculosis and HIV Coinfection in an Urban Area of Hyperendemicity
Bekker, L., & Wood, R. (2010) · Clinical Infectious Diseases · doi:10.1086/651493 · Cited by 52 · cited 4×
“care, and high rates of TB exposure (20), leading to a high”
BackgroundInfluentialQuantitative Impact of Human Immunodeficiency Virus Infection on Tuberculosis Dynamics
DeRiemer, K., Kawamura, L. M., Hopewell, P. C., & Daley, C. L. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-440oc · Cited by 51
Progress towards tuberculosis elimination: secular trend, immigration and transmission
Borgdorff, M. W., van den Hof, S., Kremer, K., Verhagen, L. M., Kalisvaart, N. A., Erkens, C. G. M., & van Soolingen, D. (2009) · European Respiratory Journal · doi:10.1183/09031936.00155409 · Cited by 51 · cited 1×
“The association between poverty, urbanization, housing density, and TB incidence is well documented (27, 50, 164, 207).”
BackgroundRandhawa, P. S. (1990) · Pathology · doi:10.3109/00313029009063555 · Cited by 51 · cited 1×
“TB is characterized histopathologically by the formation of granulomas, which are organized aggregates in which macrophages, dendritic cells, T cells, and B cells are closely apposed (215).”
BackgroundManosuthi, W., Mankatitham, W., Lueangniyomkul, A., Chimsuntorn, S., & D, S. S. M. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00563.x · Cited by 50 · cited 1×
“However, a large prospective cohort study in South Africa and a randomized clinical trial in Thailand failed to show any adverse effect on virologic suppression when a standard dose of efavirenz (600 mg daily) was used with rifampin (29, 170, 171).”
MethodTabarsi, P., Saber-Tehrani, A. S., Baghaei, P., Padyab, M., Mansouri, D., Amiri, M. V., Masjedi, M. R., & Altice, F. L. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-14 · Cited by 49
The impact of the HIV epidemic on tuberculosis transmission in Tanzania
Egwaga, S., Cobelens, F. G. J., Muwinge, H., Verhage, C., Kalisvaart, N., & Borgdorff, M. W. (2006) · AIDS · doi:10.1097/01.aids.0000218557.44284.83 · Cited by 48 · cited 1×
“However, another study in Tanzania found a decrease in the ARTI in the context of a rising HIV prevalence from 1983 to 2003 (81).”
Haddow, L. J., Moosa, M. S., & Easterbrook, P. (2009) · AIDS · doi:10.1097/qad.0b013e32832ec1f4 · Cited by 48 · cited 1×
“The 2008 INSHI case definition for TB-IRIS has been validated subsequently in a South African cohort of 498 TB-HIV-coinfected patients against expert opinion and in a Thai cohort of 126 patients against the study definition confirmed by an external reviewer (120, 172).”
MethodHIV-1 Nef Promotes Endocytosis of Cell Surface MHC Class II Molecules via a Constitutive Pathway
Chaudhry, A., Verghese, D. A., Das, S. R., Jameel, S., George, A., Bal, V., Mayor, S., & Rath, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804014 · Cited by 47 · cited 1×
“Perhaps even more significant are the observations that the HIV Nef protein downregulates HLA classes I and II at the cell surface (47), which, in turn, has been found to impair antigen-specific T cell activation in vitro (240).”
BackgroundManosuthi, W., Tieu, H., Mankatitham, W., Lueangniyomkul, A., Ananworanich, J., Avihingsanon, A., Siangphoe, U., Klongugkara, S., Likanonsakul, S., Thawornwan, U., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832f7b59 · Cited by 46 · cited 1×
“The 2008 INSHI case definition for TB-IRIS has been validated subsequently in a South African cohort of 498 TB-HIV-coinfected patients against expert opinion and in a Thai cohort of 126 patients against the study definition confirmed by an external reviewer (120, 172).”
MethodThe effects of the AIDS epidemic on the tuberculosis problem and tuberculosis programmes.
Slutkin, G., Leowski, J., & Mann, J. (1988) · PubMed · Cited by 45
Outbreak of multidrug-resistant tuberculosis at a hospital--New York City, 1991.
(1993) · PubMed · Cited by 45
Martínez‐Lirola, M., Alonso‐Rodríguez, N., Sánchez, M. L., Herránz, M., Andrés, S., Peñafiel, T., Rogado, M. C., Cabezas, T., Martínez, J., Lucerna, M. Á., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588785 · Cited by 44 · cited 1×
“However, cluster analyses in Spain suggested that recent transmission can be a significant cause of TB infections in immigrants (11, 174).”
BackgroundIncidence of Tuberculosis in Injection Drug Users in San Francisco: Impact of Anergy
DALEY, C. L., HAHN, J. A., MOSS, A. R., HOPEWELL, P. C., & SCHECTER, G. F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9701111 · Cited by 43 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodMultidrug-resistant tuberculosis at an HIV testing center in Haiti
Joseph, P., Sévère, P., Ferdinand, S., Goh, K. S., Sola, C., Haas, D. W., Johnson, W. D., Rastogi, N., Pape, J. W., & Fitzgerald, D. W. (2006) · AIDS · doi:10.1097/01.aids.0000206505.09159.9a · Cited by 43 · cited 1×
“In Port-au-Prince, Haiti, a cross-sectional study of 28,261 patients at an HIV voluntary counseling and testing (VCT) center found that 3,708 (13%) patients reported having a cough for at least 5 days, and of these patients, 925 (25%) were diagnosed with suspected or confirmed TB by sputum acid-fast bacillus (AFB) sme…”
BackgroundJenny-Avital, E. R., & Joseph, K. (2009) · Clinical Infectious Diseases · doi:10.1086/598336 · Cited by 43 · cited 3×
“This is illustrated by case reports of the development of TB relapse due to acquired rifampin resistance after treatment with everyother-day rifabutin and ritonavir-boosted PI-based ART (28, 134).”
BackgroundTuberculosis Morbidity—United States, 1991
(1992) · JAMA · doi:10.1001/jama.1992.03480180035013 · Cited by 43
The Role of the Monocyte in Tuberculosis
Cunningham, R. S., Sabin, F. R., Sugiyama, S., & Kindwall, J. A. (1925) · Profiles in Science · Cited by 41
Garcia, G. F., Moura, A. S., Ferreira, C. S., & Rocha, M. O. D. C. (2007) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822007000600004 · Cited by 40 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodTuberculosis Morbidity—United States, 1995
(1996) · JAMA · doi:10.1001/jama.1996.03530450019009 · Cited by 40
Fennelly, K. P. (2007) · Clinical Infectious Diseases · doi:10.1086/516617 · Cited by 38 · cited 1×
“Only 3 of 77 patients were responsible for over 73% of TB infections in guinea pigs, and half of all TB infections in guinea pigs were caused by one patient with laryngeal TB (91).”
BackgroundBlanc, F. –., Thim, S., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., Madec, Y., Marcy, O., Chan, S., Prak, N., et al. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s1-o11 · Cited by 38
Abouya, L., Coulibaly, I. M., Coulibaly, D., Kassim, S., Ackah, A. A. F., Greenberg, A. E., Wiktor, S. Z., & Cock, K. M. D. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90011-x · Cited by 35 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodBrainard, D. M., Kassahun, K., Wenning, L. A., Petry, A. S., Liu, C., Lunceford, J. K., Hariparsad, N., Eisenhandler, R., Norcross, A., DeNoia, E. P., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010375959 · Cited by 35
Abgrall, S., Giudice, P. D., Melica, G., & Costagliola, D. G. (2010) · AIDS · doi:10.1097/qad.0b013e3283366747 · Cited by 34 · cited 1×
“Likewise, in a French cohort of HIV-infected patients enrolled in care, over half of those with HIV-TB coinfection were immigrants, the majority from sub-Saharan Africa (5).”
BackgroundMycobacterial T Cell Responses in HIV‐Infected Patients with Advanced Immunosuppression
Hammond, A. S., McConkey, S. J., Hill, P. C., Crozier, S., Klein, M. R., Adegbola, R. A., Rowland‐Jones, S., Brookes, R. H., Whittle, H. C., & Jaye, A. (2008) · The Journal of Infectious Diseases · doi:10.1086/524685 · Cited by 31 · cited 1×
“One study found that the frequency of IFN- -producing CD4 T cells responsive to the highly immunogenic ESAT-6 or CFP-10 peptide or to an ESAT-6/CFP-10 fusion protein exhibited a negative correlation with the total CD4 T cell count in HIV-infected, antiretroviral-naïve subjects, implying that CD4 T cells responsive to…”
BackgroundCattamanchi, A., Nahid, P., Marras, T. K., Gotway, M. B., Lee, T. J., Jarlsberg, L. G., Morris, A. M., Webb, W. R., Osmond, D. H., & Daley, C. L. (2008) · CHEST Journal · doi:10.1378/chest.07-2171 · Cited by 31 · cited 1×
“Due to operator dependence on sample collection and processing and interpretation of sputum smears, the sensitivity of the sputum smear ranges from 20% to 60% in resource-constrained settings (37, 217, 236).”
BackgroundReddy, K. P., Brady, M. F., Gilman, R. H., Coronel, J., Ñavincopa, M., Ticona, E., Chávez, G., Sánchez, E., Rojas, C., Solari, L., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651081 · Cited by 30 · cited 1×
“MODS assays of sputum samples of patients with HIV infection have 98% sensitivity and 100% specificity for the detection of TB and provided results in 14 days for most samples (196, 216).”
BackgroundAlonso‐Rodríguez, N., Andrés, S., Bouza, E., Herranz, M., Serrano, M. J., de Viedma, D. G., Palenque, E., Cháves, F., Iñigo, J., Cías, R., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02670.x · Cited by 29 · cited 1×
“However, cluster analyses in Spain suggested that recent transmission can be a significant cause of TB infections in immigrants (11, 174).”
BackgroundAetiology of cavitary lung lesions in patients with HIV infection*
Lin, C., Sun, H., Chen, M., Hsieh, S., Sheng, W., Lo, Y., Hung, C., & Chang, S. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00674.x · Cited by 27 · cited 1×
“cells/ l should prompt a search for other etiologies (33, 102, 161, 210).”
BackgroundScreening for active tuberculosis in HIV testing centre
Espinal, M., Reingold, A. L., Koenig, E., LAVANDERA, M., & Sánchez, S. S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90010-1 · Cited by 27 · cited 1×
“Another study from Santo Domingo, Dominican Republic, found that almost 10% of individuals presenting for HIV testing at a VCT center had undiagnosed active TB (90).”
BackgroundMilburn, H. J. (2001) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200105000-00004 · Cited by 25
XDR-TB in South Africa: Revised Definition
Holtz, T. H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040161 · Cited by 22
Okwera, A., Johnson, J. L., Luzze, H., Nsubuga, P., Kayanja, H. K., Cohn, D. L., Nunn, P., Ellner, J. J., Whalen, C. C., & Mugerwa, R. D. (2006) · PubMed · Cited by 22
Lawn, S. D., & Wood, R. (2007) · PubMed · Cited by 21
IFN-γ release assays in tuberculosis management in selected high-risk populations
Bocchino, M., Bellofiore, B., Matarese, A., Galati, D., & Sanduzzi, A. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.9.2.165 · Cited by 21
Kawooya, V., Kawooya, M. G., & Okwera, A. (2000) · PubMed · Cited by 20
Fenton, K. A., & Elimination, T. (2014) · Cited by 19
Veldsman, C., Kock, M. M., Rossouw, T. M., Nieuwoudt, M., Maeurer, M. J., Hoosen, A. A., & Ehlers, M. M. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00610.x · Cited by 17 · cited 1×
“probably due to latent TB infection (254).”
Cavitary pulmonary tuberculosis HIV-related
Rizzi, E. B., Schininà, V., Palmieri, F., Girardi, E., & Bibbolino, C. (2004) · European Journal of Radiology · doi:10.1016/j.ejrad.2004.04.007 · Cited by 17 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
Methodda Silva, R. M., da Rosa, L., & Lemos, R. N. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000300009 · Cited by 16
Obstacles and Proposed Solutions to Effective Antiretroviral Therapy in Resource-Limited Settings
Bartlett, J. A., Hornberger, J. C., Shewade, A., Bhor, M., & Rajagopalan, R. (2009) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109709337745 · Cited by 16 · cited 1×
“In addition, HIV-infected persons living in resource-constrained settings face socioeconomic and behavioral barriers to HIV testing and access to antiretroviral treatment (16).”
BackgroundMañas, E., Pulido, F., Jm, P., Rubio, R., González‐García, J., Costa, R., Pérez-Rodríguez, E., & del Palacio, A. (2004) · PubMed · Cited by 16
Is Natural Ventilation a Useful Tool to Prevent the Airborne Spread of TB?
Wilson, P. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040077 · Cited by 11 · cited 2×
“Together, these studies highlight the need for effective infection control and ventilation as components of comprehensive strategies to prevent the spread of TB and drug-resistant TB to HIV-infected patients in waiting rooms, clinics, and hospital wards (18, 268).”
BackgroundThe clinical significance of interactions between HIV and TB: more questions than answers.
Corbett, E. L., & Cock, K. M. D. (2001) · PubMed · Cited by 9
Co-pathogenesis of tuberculosis and HIV
Lawn, S. O. (2009) · Tuberculosis · doi:10.1016/b978-1-4160-3988-4.00010-x · Cited by 9
Minion, J., & Pai, M. (2010) · Clinical Infectious Diseases · doi:10.1086/651082 · Cited by 8 · cited 2×
“Microscopic observation drug susceptibility (MODS) assays have been developed for the diagnosis of TB and the detection of drug-resistant TB (191, 192).”
MethodSilva, R. M., Rosa, L., & Lemos, R. N. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000900009 · Cited by 6
Diagnosing Tuberculosis in Patients with HIV: Do We Know Enough?
Perlman, D. C., Leung, C. C., & Yew, W. W. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200908-1226ed · Cited by 5 · cited 1×
“An evaluation of sputum smears and cultures from HIV-infected persons with culture-confirmed TB in Thailand and Vietnam found the sensitivity of three sputum smears to be only 38% (195, 211).”
BackgroundDesalu, O. O., Olokoba, A. B., Danfulani, M., Gambo, Z., Salawu, F. K., Damburam, A., & Midala, J. (2009) · Cited by 3
Research works printed but not linked: 4
- CDC. 1991. Epidemiologic notes and reports of nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR Morb. Mortal. Wkly. Rep. 40:585–591.
- Desalu O. . 2009. Impact of immunosuppression on radiographic features of HIV related pulmonary tuberculosis among Nigerians. Turk. Thorac. J. 11:112–116.
- 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
- Meintjes G. . 2009. Randomized placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome, abstr. 34. Abstr. Conf. Retrovir. Oppor. Infect. 2009, Montreal, Canada.
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 614
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
“Similarly, a range of nongenetic immunosuppression—Human ImmunodeficiencyVirus (HIV) infection, TNF-blocking and glucocorticoid treatments—increases susceptibility to TB (Kwan and Ernst, 2011; Lawn and Zumla, 2011).”
BackgroundThe immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Self-citation
Metadata
- Authors
- Kwan, C. K., & Ernst, J. D.
- Affiliations
- New York University (US)
- ORCID
- Ernst, Joel D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 24
- Issue
- 2
- Pages
- 351-376
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3122491
- OpenAlex
- W2137617609
- Cited by
- 720
- References
- 271
- Citations by year
- 2026: 31 · 2025: 42 · 2024: 40 · 2023: 64 · 2022: 55 · 2021: 51 · 2020: 66 · 2019: 43 · 2018: 59 · 2017: 53 · 2016: 47 · 2015: 45 · 2014: 40 · 2013: 34 · 2012: 46
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI090928, R01AI084041, R01AI051242)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- HIV, tuberculosis, syndemic, HIV/TB coinfection, tuberculosis elimination, disease burden, tuberculosis diagnosis, tuberculosis treatment, tuberculosis prevention, multidisciplinary approach
- MeSH terms
- Communicable Disease Control, Humans, Tuberculosis, HIV Infections, Comorbidity, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.